Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition'
Rinella, Mary E Castro Narro, Graciela E Krag, Aleksander Terrault, Norah Newsome, Philip N
Rinella, Mary E
Castro Narro, Graciela E
Krag, Aleksander
Terrault, Norah
Newsome, Philip N
Abstract
From the beginning of this process, EASL, AASLD, and ALEH have been united in advancing the field for patients with steatotic liver disease. We recognize that the journey to consensus has been challenging and, as one might expect from a consensus process addressing a topic with numerous divergent opinions, not all individual perspectives and arguments can be accommodated.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2023-12-19
Type
Correspondence
Subject
Collections
Citation
Rinella ME, Castro Narro GE, Krag A, Terrault N, Newsome PN. Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †. Hepatology. 2024 Feb 1;79(2):E16-E17. doi: 10.1097/HEP.0000000000000705. Epub 2023 Dec 19.